279 related articles for article (PubMed ID: 33463527)
1. Prognostic Impact of pT3 Subclassification in a Multicentre Cohort of Patients with Urothelial Carcinoma of the Renal Pelvicalyceal System Undergoing Radical Nephroureterectomy: A Propensity Score-weighted Analysis After Central Pathology Review.
Seisen T; Mari A; Campi R; Peyronnet B; Bensalah K; Rioux-Leclercq N; Pfister C; Gobet F; De La Taille A; Allory Y; Xylinas E; Neuzillet Y; Radulescu C; Descotes JL; Saada-Sebag G; Irani J; Delpech-Debiais C; Bigot P; Eymerit C; Crouzet S; Mege-Lechevallier F; Ruffion A; Decaussin-Petrucci M; Droupy S; Roger P; Durand X; Camparo P; Cussenot O; Compérat E; Rouprêt M
Eur Urol Focus; 2021 Sep; 7(5):1075-1083. PubMed ID: 33463527
[TBL] [Abstract][Full Text] [Related]
2. International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvis.
Roscigno M; Cha EK; Rink M; Seitz C; Novara G; Chromecki TF; Fritsche HM; Matsumoto K; Walton TJ; Carballido J; Filippo Da Pozzo L; Bertini R; Ficarra V; Otto W; Karakiewicz PI; Pycha A; Fajkovic H; Naspro R; Scherr DS; Montorsi F; Shariat SF
BJU Int; 2012 Sep; 110(5):674-81. PubMed ID: 22348322
[TBL] [Abstract][Full Text] [Related]
3. Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current TNM classification.
Shariat SF; Zigeuner R; Rink M; Margulis V; Hansen J; Kikuchi E; Kassouf W; Raman JD; Remzi M; Koppie TM; Bensalah K; Guo CC; Mikami S; Sircar K; Ng CK; Haitel A; Kabbani W; Chun FK; Wood CG; Scherr DS; Karakiewicz PI; Langner C
Eur Urol; 2012 Aug; 62(2):224-31. PubMed ID: 22285763
[TBL] [Abstract][Full Text] [Related]
4. Subclassification of pT3 upper tract urothelial carcinoma: a multicenter retrospective study.
Yamada Y; Nakagawa T; Miyakawa J; Kawai T; Taguchi S; Tabata M; Kaneko T; Ishikawa A; Miyazaki H; Kondo Y; Matsumoto A; Naito A; Hikatsu M; Fujii Y; Akiyama Y; Yamada Y; Sato Y; Nomiya A; Yamada D; Murata T; Suzuki M; Enomoto Y; Nishimatsu H; Takeuchi T; Tanaka Y; Kume H
World J Urol; 2023 Mar; 41(3):767-776. PubMed ID: 36739339
[TBL] [Abstract][Full Text] [Related]
5. pT3 subclassification of renal pelvic cancer considering the tumor location improves the patients' prognostic accuracy.
Sano T; Kato M; Sassa N; Sadachi R; Hirakawa A; Kamihira O; Hirabayashi T; Nishikimi T; Katsuno S; Kimura T; Hattori R; Gotoh M; Tsuzuki T
Virchows Arch; 2021 Jun; 478(6):1089-1097. PubMed ID: 33420835
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of subclassifying pathological T3 upper tract urothelial carcinoma: Results from a multicenter cohort study.
Suhara Y; Urabe F; Yoshihara K; Kurawaki S; Fukuokaya W; Iwatani K; Imai Y; Sakanaka K; Hisakane A; Kurauchi T; Kayano S; Onuma H; Mori K; Kimura S; Tashiro K; Tsuzuki S; Miki J; Sato S; Takahashi H; Kimura T;
Int J Urol; 2024 Feb; 31(2):125-132. PubMed ID: 37828777
[TBL] [Abstract][Full Text] [Related]
7. Peripelvic/periureteral fat invasion is independently associated with worse prognosis in pT3 upper tract urothelial carcinoma.
Park J; Park S; Song C; Hong JH; Kim CS; Ahn H
World J Urol; 2014 Feb; 32(1):157-63. PubMed ID: 23568447
[TBL] [Abstract][Full Text] [Related]
8. Ten-year survival outcomes after radical nephroureterectomy with a risk-stratified approach using prior diagnostic ureteroscopy: a single-institution observational retrospective cohort study.
Veeratterapillay R; Geraghty R; Pandian R; Roy C; Stenhouse G; Bird C; Soomro N; Paez E; Rogers A; Johnson M; Page T; Rix D; Thomas D; Rai BP
BJU Int; 2022 Jun; 129(6):744-751. PubMed ID: 34726325
[TBL] [Abstract][Full Text] [Related]
9. Microscopic invasion of perivesical fat by urothelial carcinoma: implications for prognosis and pathology practice.
Scosyrev E; Yao J; Messing E
Urology; 2010 Oct; 76(4):908-13; discussion 914. PubMed ID: 20709375
[TBL] [Abstract][Full Text] [Related]
10. Oncologic outcomes of patients treated with kidney-sparing surgery or radical nephroureterectomy for upper urinary tract urothelial cancer: a population-based study.
Ślusarczyk A; Zapała P; Zapała Ł; Rajwa P; Moschini M; Laukhtina E; Radziszewski P
Urol Oncol; 2024 Jan; 42(1):22.e1-22.e11. PubMed ID: 37981503
[TBL] [Abstract][Full Text] [Related]
11. Association between lymphovascular invasion and oncological outcome in node-negative upper tract urothelial carcinoma with different stage.
Chen CS; Lin CY; Wang CL; Wang SS; Li JR; Yang CK; Cheng CL; Chiu KY; Yang SF
Urol Oncol; 2021 Feb; 39(2):132.e13-132.e26. PubMed ID: 32900630
[TBL] [Abstract][Full Text] [Related]
12. Caveolin-1 Expression in Upper Tract Urothelial Carcinoma.
D'Andrea D; Moschini M; Foerster B; Abufaraj M; Margulis V; Karam J; Lotan Y; Raman J; Mathieu R; Rouprêt M; Karakiewicz PI; Briganti A; Haitel A; Shariat SF
Eur Urol Focus; 2019 Jan; 5(1):97-103. PubMed ID: 28753840
[TBL] [Abstract][Full Text] [Related]
13. Reassessment of prognostic heterogeneity of pT3 renal pelvic urothelial carcinoma: analysis in terms of proposed pT3 subclassification systems.
Park J; Habuchi T; Arai Y; Ohyama C; Inoue T; Hatakeyama S; Jeon SS; Kwon GY; Kwak C; Moon KC; Kim CS; Ahn H
J Urol; 2014 Oct; 192(4):1064-71. PubMed ID: 24735938
[TBL] [Abstract][Full Text] [Related]
14. Bladder mapping of tumour recurrence after radical nephroureterectomy for upper tract urothelial carcinoma and its influence on oncological outcomes.
Belhadj Y; Grande P; Seisen T; Gobert A; Gomez FD; Cussenot O; Roupret M
BJU Int; 2019 Apr; 123(4):618-623. PubMed ID: 30548115
[TBL] [Abstract][Full Text] [Related]
15. Effects of Variant Histology on the Oncologic Outcomes of Patients With Upper Urinary Tract Carcinoma After Radical Nephroureterectomy: A Propensity Score-Matched Analysis.
Chung HS; Hwang EC; Kim MS; Yu SH; Jung SI; Kang TW; Choi C; Choi SH; Kwon TG; Noh JH; Kim MK; Cho WJ; Kang SG; Kang SH; Cheon J; Seo IY; Chung H; Kim HS; Lee CH; Ku JY; Ha HK; Kim BH; Jeong CW; Ku JH; Kwak C; Kwon D
Clin Genitourin Cancer; 2019 Jun; 17(3):e394-e407. PubMed ID: 30782419
[TBL] [Abstract][Full Text] [Related]
16. High Infiltration of CD163-Positive Macrophages in Intratumor Compartment Predicts Poor Prognosis in Patients With Upper Urinary Tract Urothelial Carcinoma and Radical Nephroureterectomy.
Kobayashi Y; Arai H; Hamamoto Y; Yoshida K; Shimizu S; Yasuhara Y; Ichimaru N
Clin Genitourin Cancer; 2023 Oct; 21(5):e386-e393. PubMed ID: 37244798
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
[TBL] [Abstract][Full Text] [Related]
18. A Novel Risk-based Approach Simulating Oncological Surveillance After Radical Nephroureterectomy in Patients with Upper Tract Urothelial Carcinoma.
Shigeta K; Kikuchi E; Abe T; Hagiwara M; Ogihara K; Anno T; Umeda K; Baba Y; Sanjo T; Shojo K; Mikami S; Mizuno R; Oya M
Eur Urol Oncol; 2020 Dec; 3(6):756-763. PubMed ID: 31395480
[TBL] [Abstract][Full Text] [Related]
19. Is pT3 urothelial carcinoma of the renal pelvis a homogeneous disease entity? Proposal for a new subcategory of the pT3 classification.
Sassa N; Tsuzuki T; Fukatsu A; Majima T; Kimura T; Nishikimi T; Yoshino Y; Hattori R; Gotoh M
Histopathology; 2012 Oct; 61(4):620-8. PubMed ID: 22730905
[TBL] [Abstract][Full Text] [Related]
20. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.
Godfrey MS; Badalato GM; Hruby GW; Razmjoo M; McKiernan JM
BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
